Could Alzheimer’s treatment drugs be the next big investor opportunity after obesity pills?
Alzheimer’s drugs could unlock a $13 billion market by 2030, with Biogen, Eli Lilly, Novo Nordisk, Roche, and UCB leading the ...
Hosted on MSN2d
Breakthrough drugs herald ‘new era’ in battle against dementia, experts predict
Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
Undark3d
Why Alzheimer’s Scientists Are Re-thinking the Amyloid Hypothesis
Recent studies implicate the immune system and a herpes virus as potential contributors to development of the disease.
Alzheimer's Society3d
Alzheimer's Society Blog
Here, we look at some words and questions to try to avoid when talking to a person with dementia. ... With announcements on new Alzheimer's drugs, the launch of essential care research partnerships, ...
The new weight loss jab trick the A-listers love... and it doesn't just keep the weight off, there's a raft of other health benefits and NO side effects
When I began Ozempic, in April 2023, I was in the doldrums of perimenopause, with high cholesterol, prediabetic blood sugar ...
Taking Vitamin D Could Help Prevent Dementia, Recent Study Suggests: Here's Why
Vitamin D also helps clear beta amyloid, a protein that plays a role in Alzheimer’s disease, Merrill points out. This is “the ...
Should California’s right-to-die law expand to include people with dementia? OC legislator wants to consider it
State Sen. Catherine Blakespear wants to engage stakeholder groups to discuss possible changes to the law, but she faces ...
Psychology Today13d
Antipsychotics Use May Worsen Behavior in Nursing Homes
This University of Waterloo study shows how antipsychotic medications significantly worsened behavior in nursing home ...
Anavex Life Sciences: Jumping In On Time Ahead Of An Early Alzheimer's Decision
Anavex Life Sciences' ANAVEX 2-73 shows promise in treating Alzheimer's, with strong efficacy in slowing cognitive and ...
psychiatryadvisor.com15d
Reduce Risk of Dementia by Combining Cardiovascular Disease Drug Classes
lipid-lowering drug, OAC, and/or renin–angiotensin system (RAS)–acting agent use since 2005. Long-term use was defined as 5 years or longer. In total, there were 88,065 dementia diagnosis ...
AARP15d
25 Great Ways to Manage Your Medications
This is especially true for insulin-dependent diabetics, heart conditions, seizure disorders, allergies to medications and dementia patients who may wander ... medically speaking. “If there are ...